Primary prevention of cardiovascular disease with statins: cautionary notes

Autor:	Luca Mascitelli, Mark R. Goldstein, Francesca Pezzetta
Rok vydání:	2009
Předmět:	Oncology medicine.medical_specialty Statin business.industry Vascular disease medicine.drug_class Cancer General Medicine Disease medicine.disease Transplantation Immune system Breast cancer Internal medicine Immunology Medicine lipids (amino acids peptides and proteins) Progenitor cell business
Zdroj:	QJM. 102:817-820
ISSN:	1460-2393 1460-2725
Popis:	Sir, In his informative commentary on the importance of primary prevention in reducing the burden of vascular disease,1 Dr Miller states that compliance problems with lifestyle changes facilitate the pharmacologic treatment with statins to achieve low-density lipoprotein (LDL) cholesterol lowering goals. It's noteworthy that prominent thought leaders now suggest that 100 million Americans should be on statin therapy (instead of the 16 million Americans presently on statin therapy) and everyone should have a LDL cholesterol level
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bfd606ec8d5036a92fc515479a5141fc https://doi.org/10.1093/qjmed/hcp099 Zobrazit plný text záznamu